VEGFA and type 2 diabetes mellitus: Therefore, early and accurate identification of DR and disease progression among T2DM patients is essential for clinicians when evaluating the disease status of patients and formulating suitable therapy efforts such as anti-vascular endothelial growth-factor agents, intraocular injection of steroids or timely laser therapy for preservation of sight in DR patients.